Does statin suppress oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer? A single-center observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Does statin suppress oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer? A single-center observational study ; volume:31 ; number:11 ; day:28 ; month:10 ; year:2023 ; pages:1-6 ; date:11.2023
Supportive care in cancer ; 31, Heft 11 (28.10.2023), 1-6, 11.2023
- Urheber
-
Okamoto, Kazuaki
Nozawa, Hiroaki
Emoto, Shigenobu
Murono, Koji
Sasaki, Kazuhito
Ishihara, Soichiro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-023-08134-2
- URN
-
urn:nbn:de:101:1-2024022914070095081105
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Okamoto, Kazuaki
- Nozawa, Hiroaki
- Emoto, Shigenobu
- Murono, Koji
- Sasaki, Kazuhito
- Ishihara, Soichiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
The implications of statin induced peripheral neuropathy
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
Statin use and peripheral sensory neuropathy: a pilot study
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy
Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
Rituximab in non-systemic vasculitic neuropathy: a single-center experience
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
Single-center experience of induction therapy in non-systemic vasculitic neuropathy
The implications of statin induced peripheral neuropathy
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
Statin use and peripheral sensory neuropathy: a pilot study
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy
Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
Rituximab in non-systemic vasculitic neuropathy: a single-center experience
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
Single-center experience of induction therapy in non-systemic vasculitic neuropathy
The implications of statin induced peripheral neuropathy
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
Statin use and peripheral sensory neuropathy: a pilot study
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy
Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
Rituximab in non-systemic vasculitic neuropathy: a single-center experience
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development